EUVIMEDEUVIMED entdecken
Crossref

Transarterial Embolisation as Palliative Therapy for Oral Tumours in Canine and Feline Patients: A Retrospective Case Series

Sunghoon Jeon, Gahyun Lee, Jin-Kyung Kim, Hyo-Cheol Kim, Namsoon Lee iD, Dongwoo Chang

Veterinary and Comparative Oncology · 2026

DOI: 10.1111/vco.70043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, 2026. Verfasst von Sunghoon Jeon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Haemaru Referral Animal Hospital, Seongnam, Republic of Korea. Hauptthemen laut MEDLINE: Mouth Neoplasms, Cat Diseases, Dog Diseases, Palliative Care. Die Arbeit nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In human medicine, transarterial embolisation (TAE) is widely used to manage inoperable tumours and intractable haemorrhages. However, its application in veterinary patients with oral tumours remains limited. Accordingly, we aimed to investigate the clinical utility of TAE using polyvinyl alcohol particles for the treatment of oral neoplasms in dogs and cats. We included 15 dogs and cats with oral neoplasia. The tumour types included squamous cell carcinoma (SCC), melanoma and chondrosarcoma. All patients underwent intra‐arterial administration of carboplatin, followed by selective embolisation of the tumour‐feeding arteries. There was a significant post‐procedural improvement in clinical signs such as oral bleeding and anorexia ( p < 0.05). Follow‐up computed tomography imaging findings, which were available for 12 patients, demonstrated a significant tumour volume reduction of 50.66% (95% confidence interval: 10.46%–83.92%; p = 0.002). There were no major complications, with minor adverse events such as skin ulceration or transient pain being self‐limiting. Among the 15 patients, 13 died during the study period, with survival times ranging from 60 to 499 days. Two patients were still alive at the time of analysis, at 305 and 406 days, respectively. When categorised by species and tumour type, dogs with SCC survived for 60–305 days, cats with SCC for 70–291 days, dogs with melanoma for 77–406 days and the two dogs with chondrosarcoma survived for 103 and 499 days, respectively. These findings suggest that TAE is a well‐tolerated, minimally invasive treatment that can effectively reduce the tumour burden and clinical symptoms in veterinary patients with oral tumours.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsCat DiseasesDog DiseasesPalliative CareEmbolization, TherapeuticAnimalsCatsDogsRetrospective StudiesFemaleMaleCarcinoma, Squamous CellAntineoplastic AgentsMelanomaCarboplatinChondrosarcoma

Stichwörter der Autor:innen

interventional radiologyoral tumourstransarterial embolisation

Substanzen

Antineoplastic AgentsCarboplatin

Autor:innen und Institutionen

  • Haemaru Referral Animal Hospital, Seongnam, Republic of Korea.
  • Seoul National University Hospital, Department of Radiology, Seoul, Republic of Korea.
  • College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of Korea.

ORCID-Profile: Namsoon Lee

Zitieren

APA

Jeon, S., Lee, G., Kim, J. K., Kim, H. C., Lee, N., & Chang, D. (2026). Transarterial Embolisation as Palliative Therapy for Oral Tumours in Canine and Feline Patients: A Retrospective Case Series. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.70043

Vancouver

Jeon S, Lee G, Kim JK, Kim HC, Lee N, Chang D. Transarterial Embolisation as Palliative Therapy for Oral Tumours in Canine and Feline Patients: A Retrospective Case Series. Veterinary and Comparative Oncology. 2026. doi:10.1111/vco.70043

BibTeX
@article{Jeon2026,
  author = {Jeon, Sunghoon and Lee, Gahyun and Kim, Jin-Kyung and Kim, Hyo-Cheol and Lee, Namsoon and Chang, Dongwoo},
  title = {Transarterial Embolisation as Palliative Therapy for Oral Tumours in Canine and Feline Patients: A Retrospective Case Series},
  journal = {Veterinary and Comparative Oncology},
  year = {2026},
  doi = {10.1111/vco.70043}
}
Kostenlos starten →